Gateway Investment Advisers LLC Biomarin Pharmaceutical Inc Transaction History

Gateway Investment Advisers LLC

$9 Billion
Q3 2024

A detailed history of Gateway Investment Advisers LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Gateway Investment Advisers LLC holds 4,449 shares of BMRN stock, worth $291,187. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,449

Previous 12,671 64.89%

Holding current value

$291,187

Previous $1.04 Million 70.09%

% of portfolio

0.0%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$69.02 - $93.84 $567,482 - $771,552	-8,222 Reduced 64.89%	4,449 $312,000
Q2 2024 Jul 12, 2024	SELL	$74.43 - $92.22 $643,745 - $797,610	-8,649 Reduced 40.57%	12,671 $1.04 Million
Q1 2024 Apr 12, 2024	BUY	$83.81 - $99.0 $705,261 - $833,085	8,415 Added 65.21%	21,320 $1.86 Million
Q3 2023 Oct 19, 2023	SELL	$85.07 - $94.48 $13,866 - $15,400	-163 Reduced 1.25%	12,905 $1.14 Million
Q2 2023 Jul 13, 2023	SELL	$86.68 - $100.3 $2.1 Million - $2.43 Million	-24,215 Reduced 64.95%	13,068 $1.13 Million
Q1 2023 Apr 11, 2023	SELL	$87.74 - $117.27 $37,377 - $49,957	-426 Reduced 1.13%	37,283 $3.63 Million
Q4 2022 Jan 13, 2023	SELL	$80.93 - $108.63 $5,988 - $8,038	-74 Reduced 0.2%	37,709 $0
Q3 2022 Oct 07, 2022	BUY	$82.16 - $96.94 $1,643 - $1,938	20 Added 0.05%	37,783 $3.2 Million
Q2 2022 Jul 13, 2022	BUY	$71.48 - $86.85 $81,058 - $98,487	1,134 Added 3.1%	37,763 $3.13 Million
Q1 2022 Apr 14, 2022	BUY	$74.28 - $92.69 $1.96 Million - $2.45 Million	26,434 Added 259.28%	36,629 $2.82 Million
Q4 2021 Jan 14, 2022	BUY	$71.72 - $91.47 $14,128 - $18,019	197 Added 1.97%	10,195 $901,000
Q3 2021 Oct 22, 2021	SELL	$74.77 - $85.47 $4,261 - $4,871	-57 Reduced 0.57%	9,998 $773,000
Q2 2021 Jul 13, 2021	SELL	$75.51 - $84.79 $8,306 - $9,326	-110 Reduced 1.08%	10,055 $839,000
Q1 2021 Apr 14, 2021	SELL	$74.73 - $90.69 $12,405 - $15,054	-166 Reduced 1.61%	10,165 $768,000
Q4 2020 Jan 14, 2021	BUY	$72.61 - $90.2 $1,452 - $1,804	20 Added 0.19%	10,331 $906,000
Q3 2020 Oct 19, 2020	SELL	$71.87 - $131.03 $7,258 - $13,234	-101 Reduced 0.97%	10,311 $784,000
Q2 2020 Jul 15, 2020	SELL	$79.55 - $124.22 $2,704 - $4,223	-34 Reduced 0.33%	10,412 $1.28 Million
Q1 2020 Apr 13, 2020	SELL	$71.37 - $96.85 $232,737 - $315,827	-3,261 Reduced 23.79%	10,446 $883,000
Q4 2019 Jan 09, 2020	SELL	$64.27 - $86.37 $377,136 - $506,819	-5,868 Reduced 29.98%	13,707 $1.16 Million
Q3 2019 Oct 15, 2019	SELL	$67.4 - $85.11 $1,685 - $2,127	-25 Reduced 0.13%	19,575 $1.32 Million
Q2 2019 Jul 17, 2019	SELL	$80.35 - $93.9 $7,793 - $9,108	-97 Reduced 0.49%	19,600 $1.68 Million
Q1 2019 Apr 10, 2019	BUY	$84.2 - $98.62 $4,462 - $5,226	53 Added 0.27%	19,697 $1.75 Million
Q4 2018 Jan 14, 2019	BUY	$80.14 - $106.07 $462,568 - $612,236	5,772 Added 41.61%	19,644 $1.67 Million
Q3 2018 Oct 16, 2018	SELL	$93.92 - $105.72 $3,381 - $3,805	-36 Reduced 0.26%	13,872 $1.35 Million
Q2 2018 Jul 11, 2018	SELL	$76.01 - $99.03 $3,040 - $3,961	-40 Reduced 0.29%	13,908 $1.31 Million
Q1 2018 Apr 12, 2018	BUY	$77.67 - $92.63 $331,573 - $395,437	4,269 Added 44.11%	13,948 $1.13 Million
Q4 2017 Jan 17, 2018	BUY	$80.76 - $95.13 $781,676 - $920,763	9,679	9,679 $863,000

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.2B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gateway Investment Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gateway Investment Advisers LLC with notifications on news.

Account

Gateway Investment Advisers LLC Biomarin Pharmaceutical Inc Transaction History